Arkolith/Insider Trading/NORD/Form 4

Alteral Therapeutics ApS

10% OwnerNordicus Partners Corp (NORD) · full profile →Form 4 · filed Dec 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2024Other(J)4.0M——5.3M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-049432) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML